These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 35892885)

  • 81. Proton therapy for small cell lung cancer.
    Verma V; Choi JI; Simone CB
    Transl Lung Cancer Res; 2018 Apr; 7(2):134-140. PubMed ID: 29876312
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Stereotactic Ablative Radiotherapy for stage I histologically proven non-small cell lung cancer: an Italian multicenter observational study.
    Ricardi U; Frezza G; Filippi AR; Badellino S; Levis M; Navarria P; Salvi F; Marcenaro M; Trovò M; Guarneri A; Corvò R; Scorsetti M
    Lung Cancer; 2014 Jun; 84(3):248-53. PubMed ID: 24681279
    [TBL] [Abstract][Full Text] [Related]  

  • 83. A comparison between accelerated hypofractionation and stereotactic ablative radiotherapy (SABR) for early-stage non-small cell lung cancer (NSCLC): Results of a propensity score-matched analysis.
    Chiang A; Thibault I; Warner A; Rodrigues G; Palma D; Soliman H; Jain S; Poon I; Cheung P
    Radiother Oncol; 2016 Mar; 118(3):478-84. PubMed ID: 26795773
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Salvage proton beam therapy for locoregional recurrence of non-small cell lung cancer.
    Shin H; Noh JM; Pyo H; Ahn YC; Oh D
    Radiat Oncol J; 2021 Mar; 39(1):24-32. PubMed ID: 33794571
    [TBL] [Abstract][Full Text] [Related]  

  • 85. [Proton beam therapy with concurrent chemotherapy for non-small cell lung cancer -- our experiences and future direction].
    Niho S; Motegi A; Akimoto T
    Gan To Kagaku Ryoho; 2015 Feb; 42(2):144-7. PubMed ID: 25743132
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Hypofractionated high-dose proton beam therapy for stage I non-small-cell lung cancer: preliminary results of a phase I/II clinical study.
    Hata M; Tokuuye K; Kagei K; Sugahara S; Nakayama H; Fukumitsu N; Hashimoto T; Mizumoto M; Ohara K; Akine Y
    Int J Radiat Oncol Biol Phys; 2007 Jul; 68(3):786-93. PubMed ID: 17379439
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Hypofractionated Image-guided Radiation Therapy (3Gy/fraction) in Patients Affected by Inoperable Advanced-stage Non-small Cell Lung Cancer After Long-term Follow-up.
    Agolli L; Valeriani M; Bracci S; Nicosia L; DE Sanctis V; Enrici RM; Osti MF
    Anticancer Res; 2015 Oct; 35(10):5693-700. PubMed ID: 26408745
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Stereotactic body radiotherapy improves the survival of patients with oligometastatic non-small cell lung cancer.
    Ouyang W; Yu J; Nuerjiang S; Li Z; Wang D; Wang X; Zhang J; Xie C
    Cancer Med; 2019 Aug; 8(10):4605-4614. PubMed ID: 31245933
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Correlation of biologically effective dose and the tumor control in Stage I (<5 cm) non-small cell lung cancer with stereotactic ablative radiotherapy: a single institutional cohort study.
    Jeon W; Ahn SJ; Kim YC; Oh IJ; Park CK; Jeong JU; Yoon MS; Song JY; Nam TK; Chung WK
    Jpn J Clin Oncol; 2018 Feb; 48(2):144-152. PubMed ID: 29194510
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Five- Versus Ten-Fraction Regimens of Stereotactic Body Radiation Therapy for Primary and Metastatic NSCLC.
    Steber CR; Hughes RT; Soike MH; Jacobson T; Helis CA; Farris JC; Farris MK
    Clin Lung Cancer; 2021 Jan; 22(1):e122-e131. PubMed ID: 33046359
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Phase II Study of Hypofractionated Proton Beam Therapy for Hepatocellular Carcinoma.
    Kim TH; Park JW; Kim BH; Oh ES; Youn SH; Moon SH; Kim SS; Woo SM; Koh YH; Lee WJ; Kim DY
    Front Oncol; 2020; 10():542. PubMed ID: 32411594
    [No Abstract]   [Full Text] [Related]  

  • 92. Posttreatment Immune Parameters Predict Cancer Control and Pneumonitis in Stage I Non-Small-Cell Lung Cancer Patients Treated With Stereotactic Ablative Radiotherapy.
    Zheng Y; Shi A; Wang W; Yu H; Yu R; Li D; Xu B; Ma H; You J; Zhao D; Jiang L; Geng J; Zhu G
    Clin Lung Cancer; 2018 Jul; 19(4):e399-e404. PubMed ID: 29519614
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Proton therapy for early-stage non-small cell lung cancer (NSCLC).
    Gomez DR; Li H; Chang JY
    Transl Lung Cancer Res; 2018 Apr; 7(2):199-204. PubMed ID: 29876319
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Is pulmonary artery a dose-limiting organ at risk in non-small cell lung cancer patients treated with definitive radiotherapy?
    Ma JT; Sun L; Sun X; Xiong ZC; Liu Y; Zhang SL; Huang LT; Han CB
    Radiat Oncol; 2017 Feb; 12(1):34. PubMed ID: 28143532
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Proton-beam radiotherapy for early-stage lung cancer.
    Bush DA; Slater JD; Bonnet R; Cheek GA; Dunbar RD; Moyers M; Slater JM
    Chest; 1999 Nov; 116(5):1313-9. PubMed ID: 10559093
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Proton beam therapy for extrahepatic biliary tract cancer: Analysis with prospective multi-institutional patients' registration database, Proton-Net.
    Yamazaki H; Shibuya K; Kimoto T; Suzuki M; Murakami M; Terashima K; Okimoto T; Iizumi T; Sakurai H; Wakatsuki M; Suzuki O; Katoh N; Arimura T; Ogino T; Takagi M; Araya M; Waki T; Matsumoto S; Ogino H; Fukumoto T; Ohtsuka M
    Clin Transl Radiat Oncol; 2023 Jul; 41():100634. PubMed ID: 37234735
    [TBL] [Abstract][Full Text] [Related]  

  • 97. A meta-analysis comparing efficacy and safety between proton beam therapy versus carbon ion radiotherapy.
    Jang JY; Kim K; Chen MF; Akimoto T; Wang MLC; Kim MJ; Kim K; Lee TH; Yoo GS; Park HC
    Cancer Med; 2024 Feb; 13(3):e7023. PubMed ID: 38396380
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Comparing 90-Day Postoperative Mortality After Neoadjuvant Proton-Based Versus Photon-Based Chemoradiotherapy for Esophageal Cancer.
    Damen PJJ; van Rossum PSN; Chen Y; Abana CO; Liao Z; Hobbs BP; Mohan R; Blum-Murphy M; Hofstetter WL; Lin SH
    Int J Part Ther; 2024 Mar; 11():100012. PubMed ID: 38757082
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Proton Beam Therapy for Lung Oligometastatic Recurrence in Patients With Esophageal Cancer.
    Yamaguchi H; Kato T; Honda M; Hamada K; Ishikawa Y; Seto I; Takagawa Y; Suzuki M; Kikuchi Y; Murakami M
    Cureus; 2023 Dec; 15(12):e50343. PubMed ID: 38205500
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Outcome after proton beam therapy versus photon-based radiation therapy in childhood-onset craniopharyngioma patients-results of KRANIOPHARYNGEOM 2007.
    Friedrich C; Boekhoff S; Bischoff M; Beckhaus J; Sowithayasakul P; Calaminus G; Eveslage M; Valentini C; Bison B; Harrabi SB; Krause M; Timmermann B; Müller HL
    Front Oncol; 2023; 13():1180993. PubMed ID: 37965466
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.